New advances in the management of biliary tract cancer

HPB

Volumn 9, Issue 2, 2007, Pages 104-111

  Bridgewater, John ^a   Imber, Charles ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Biliary tract cancer; Chemotherapy; Clinical trials; Photodynamic therapy; Surgery

Indexed keywords

3 AMINOPICOLINALDEHYDE THIOSEMICARBAZONE; BORTEZOMIB; CAPECITABINE; FLUOROURACIL; GEMCITABINE; IXABEPILONE; MITOMYCIN C; PEMETREXED;

BILIARY TRACT CANCER; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER RESECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHOTODYNAMIC THERAPY; REVIEW; STENT;

EID: 34247576204     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820701216216     Document Type: Review

References (42)

1. Patel, T. (2001) Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33, pp. 1353-1357.
2. Nakeeb, A., Pitt, HA, Sohn, TA, Coleman, J., Abrams, RA and Piantadosi, S. (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg, 224, pp. 463-473.
3. Abraham, SC, Lee, JH, Hruban, RH, Argani, P., Furth, EE and Wu, TT (2003) Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol, 34, pp. 902-910.
4. Kang, YK, Kim, WH and Jang, JJ. (2002) Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol, 33, pp. 877-883.
5. Ito, Y., Takeda, T., Sasaki, Y., Sakon, M., Monden, M. and Yamada, T. (2000) Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes. Oncology, 59, pp. 63-67.
6. Huppertz, A., Haraida, S., Kraus, A., Zech, CJ, Scheidler, J. and Breuer, J. (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: Correlation with histopathologic findings and spiral CT-initial observations. Radiology, 234, pp. 468-478.
7. Fritscher-Ravens, A., Broering, DC, Knoefel, WT, Rogiers, X., Swain, P. and Thonke, F. (2004) EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am J Gastroenterol, 99, pp. 45-51.
8. Anderson, CD, Rice, MH, Pinson, CW, Chapman, WC, Chari, RS and Delbeke, D. (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg, 8, pp. 90-97.
9. Nimura, Y., Kamiya, J., Kondo, S., Nagino, M., Uesaka, K. and Oda, K. (2000) Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg, 7, pp. 155-162.
10. Nimura, Y., Kamiya, J., Nagino, M., Kanai, M., Uesaka, K. and Kondo, S. (1998) Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg, 5, pp. 52-61.
11. Liu, CL, Fan, ST, Lo, CM, Tso, WK, Lam, CM and Wong, J. (2006) Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg, 93, pp. 1488-1494.
12. Neuhaus, P., Jonas, S., Bechstein, WO, Lohmann, R., Radke, C. and Kling, N. (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg, 230, pp. 808-818.
13. Shimoda, M., Farmer, DG, Colquhoun, SD, Rosove, M., Ghobrial, RM and Yersiz, H. (2001) Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature. Liver Transpl, 7, pp. 1023-1033.
14. Sudan, D., DeRoover, A., Chinnakotla, S., Fox, I., Shaw Jr, B. and McCashland, T. (2002) Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant, 2, pp. 774-779.
15. Kitagawa, Y., Nagino, M., Kamiya, J., Uesaka, K., Sano, T. and Yamamoto, H. (2001) Lymph node metastasis from hilar cholangiocarcinoma: Audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg, 233, pp. 385-392.
16. Kosuge, T., Yamamoto, J., Shimada, K., Yamasaki, S. and Makuuchi, M. (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg, 230, pp. 663-671.
17. Heimbach, JK, Haddock, MG, Alberts, SR, Nyberg, SL, Ishitani, MB and Rosen, CB (2004) Transplantation for hilar cholangiocarcinoma. Liver Transpl;10(10 Suppl, 2, pp. S65-S68.
18. Bartlett, DL, Fong, Y., Fortner, JG, Brennan, MF and Blumgart, LH (1996) Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg, 224, pp. 639-646.
19. Madariaga, JR, Iwatsuki, S., Todo, S., Lee, RG, Irish, W. and Starzl, TE (1998) Liver resection for hilar and peripheral cholangiocarcinomas: A study of 62 cases. Ann Surg, 227, pp. 70-79.
20. Jarnagin, WR, Fong, Y., DeMatteo, RP, Gonen, M., Burke, EC and Bodniewicz, BSJ (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg, 234, pp. 507-517.
21. Huang, JL, Biehl, TR, Lee, FT, Zimmer, PW and Ryan Jr, JA (2004) Outcomes after resection of cholangiocellular carcinoma. Am J Surg, 187, pp. 612-617.
22. Rea, DJ, Munoz-Juarez, M., Farnell, MB, Donohue, JH, Que, FG and Crownhart, B. (2004) Major hepatic resection for hilar cholangiocarcinoma: Analysis of 46 patients. Arch Surg, 139, pp. 514-523.
23. Tsukada, K., Hatakeyama, K., Kurosaki, I., Uchida, K., Shirai, Y. and Muto, T. (1996) Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery, 120, pp. 816-821.
24. Puhalla, H., Wild, T., Bareck, E., Pokorny, H., Ploner, M. and Soliman, T. (2002) Long-term follow-up of surgically treated gallbladder cancer patients. Eur J Surg Oncol, 28, pp. 857-863.
25. Takada, T., Amano, H., Yasuda, H., Nimura, Y., Matsushiro, T. and Kato, H. (2002) Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer, 95, pp. 1685-1695.
26. Urego, M., Flickinger, JC and Carr, BI (1999) Radiotherapy and multimodality management of cholangiocarcinoma. Int J Radiat Oncol Biol Phys, 44, pp. 121-126.
27. Shiina, T., Mikuriya, S., Uno, T., Toita, T., Serizawa, S. and Itami, J. (1992) Radiotherapy of cholangiocarcinoma: The roles for primary and adjuvant therapies. Cancer Chemother Pharmacol, 31, pp. S115-S118.
28. Flickinger, JC, Epstein, AH, Iwatsuki, S., Carr, BI and Starzl, TE (1991) Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer, 68, pp. 289-294.
29. Lu, JJ, Bains, YS, Abdel-Wahab, M., Brandon, AH, Wolfson, AH and Raub, WA (2002) High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma. Cancer J, 8, pp. 74-78.
30. Todoroki, T., Iwasaki, Y., Okamura, T., Nagoshi, K., Asakura, H. and Nakano, M. (1980) Intraoperative radiotherapy for advanced carcinoma of the biliary system. Cancer, 46, pp. 2179-2184.
31. Hsue, V., Wong, CS, Moore, M., Erlichman, C., Cummings, BJ and MacLeod, M. (1996) A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma. Int J Radiat Oncol Biol Phys, 34, pp. 445-450.
32. Whittington, R., Neuberg, D., Tester, WJ, Benson, AB 3rd and Haller, DG (1995) Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: A phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol, 13, pp. 227-232.
33. Ayaru, L., Bown, SG and Pereira, SP (2005) Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer, 35, pp. 1-13.
34. Ortner, ME, Caca, K., Berr, F., Liebetruth, J., Mansmann, U. and Huster, D. (2003) Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study. Gastroenterology, 125, pp. 1355-1363.
35. Armstrong, A. and Valle, J. (2005) Investigation and management of biliary tract cancer. The effective management of upper gastrointestinal malignancies, Aesculapius Medical Press, London
36. Glimelius, B., Hoffman, K., Sjoden, PO, Jacobsson, G., Sellstrom, H. and Enander, LK (1996) Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol, 7, pp. 593-600.
37. Takada, T., Nimura, Y., Katoh, H., Nagakawa, T., Nakayama, T. and Matsushiro, T. (1998) Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: Multicenter randomized trial. Hepatogastroenterology, 45, pp. 2020-2026.
38. Kornek, GV, Schuell, B., Laengle, F., Gruenberger, T., Penz, M. and Karall, K. (2004) Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: A randomised phase II trial. Ann Oncol, 15, pp. 478-483.
39. Ducreux, M., Van Cutsem, E., Van Laethem, JL, Gress, TM, Jeziorski, K. and Rougier, P. (2005) EORTC Gastro Intestinal Tract Cancer Group. A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: Results of the 40955 EORTC trial. Eur J Cancer, 41, pp. 398-403.
40. Rao, S., Cunningham, D., Hawkins, RE, Hill, ME, Smith, D. and Daniel, F. (2005) Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer, 92, pp. 1650-1654.
41. Valle, JW, Wasan, H., Johnson, P., Bridgewater, J., Maraveyas, A. and Jones, E. Gemcitabine, alone or in combination with cisplatin, in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: A multicentre, randomised phase II study. ASCO GI January 2006
42. Pereira, S., Ragunath, K., Devlin, J. and Meadows, H. Preliminary results of a phase 2 trial to examine the safety and efficacy of porfimer sodium PDT in locally advanced BTC.